Published in Can J Psychiatry on December 01, 2014
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet (2004) 39.54
A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry (1978) 25.54
Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ (2005) 5.34
Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol (2005) 4.49
Global assessment of functioning. A modified scale. Psychosomatics (1995) 4.48
An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med (2003) 4.20
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord (2009) 3.56
Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr Psychiatry (2006) 3.48
Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord (2003) 3.23
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord (2012) 3.01
Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord (2008) 2.95
Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl) (2010) 2.44
Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med (2007) 2.44
The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging (2005) 2.39
Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry (2013) 2.34
Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol (2000) 2.16
Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord (2005) 2.12
Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology (2006) 2.11
Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand Suppl (2007) 2.09
A review of the association between obesity and cognitive function across the lifespan: implications for novel approaches to prevention and treatment. Obes Rev (2011) 1.98
The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC). Bipolar Disord (2010) 1.90
Body mass index, other cardiovascular risk factors, and hospitalization for dementia. Arch Intern Med (2005) 1.81
Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry (2003) 1.73
Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res (2011) 1.71
Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch Gen Psychiatry (1998) 1.68
BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study. Neurobiol Learn Mem (2008) 1.68
Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study. Am J Clin Nutr (2008) 1.65
Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med (2006) 1.50
Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry (2009) 1.46
Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord (2002) 1.36
Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry (2002) 1.34
Meta-analysis of neuropsychological functioning in euthymic bipolar disorder: an update and investigation of moderator variables. Bipolar Disord (2011) 1.33
Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. J Clin Psychiatry (2003) 1.30
Evidence of executive dysfunction in extremely obese adolescents: a pilot study. Surg Obes Relat Dis (2009) 1.28
Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Ann Clin Psychiatry (2008) 1.26
Selective alterations within executive functions in adolescents with excess weight. Obesity (Silver Spring) (2010) 1.17
Serum brain-derived neurotrophic factor is associated with cognitive function in healthy older adults. J Geriatr Psychiatry Neurol (2008) 1.16
The MATRICS consensus cognitive battery in patients with bipolar I disorder. Neuropsychopharmacology (2011) 1.15
Body mass index and neuropsychological function in healthy children and adolescents. Appetite (2007) 1.11
Altered executive function in obesity. Exploration of the role of affective states on cognitive abilities. Appetite (2009) 1.06
The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients. Bipolar Disord (2007) 1.04
Relationship between cognitive functioning and 6-month clinical and functional outcome in patients with first manic episode bipolar I disorder. Psychol Med (2011) 0.97
Weight gain in bipolar disorder: pharmacological treatment as a contributing factor. Acta Psychiatr Scand (2008) 0.97
The burden of obesity among adults with bipolar disorder in the United States. Bipolar Disord (2011) 0.96
Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode. J Clin Psychiatry (2010) 0.95
Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study. Neurosci Lett (2011) 0.93
Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients. Compr Psychiatry (2011) 0.93
Early childhood obesity is associated with compromised cerebellar development. Dev Neuropsychol (2009) 0.92
Long-term outcome of cognitive impairment in bipolar disorder. J Clin Psychiatry (2012) 0.92
Tolerability profiles of atypical antipsychotics in the treatment of bipolar disorder. J Clin Psychiatry (2005) 0.91
Comparison of cognitive functions between first- and multi-episode bipolar affective disorders. J Affect Disord (2006) 0.88
The effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder. Eur Psychiatry (2011) 0.87
Course and outcome after the first manic episode in patients with bipolar disorder: prospective 12-month data from the Systematic Treatment Optimization Program For Early Mania project. Can J Psychiatry (2009) 0.86
Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation. Neurosci Lett (2011) 0.86
Neurocognitive functioning in patients recently diagnosed with bipolar disorder. Bipolar Disord (2012) 0.85
Brain-derived neurotrophic factor serum levels before and after treatment for acute mania. Neurosci Lett (2009) 0.85
The association of elevated body mass index with reduced brain volumes in first-episode mania. Biol Psychiatry (2011) 0.83
12-month longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder. Bipolar Disord (2014) 0.82
The association of weight gain with mood symptoms and functional outcomes following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). Bipolar Disord (2010) 0.81
Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder. Int Clin Psychopharmacol (2012) 0.79
The impact of childhood trauma on cognitive functioning in patients recently recovered from a first manic episode: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). J Affect Disord (2012) 0.78
Neuropsychological functions in Han Chinese patients in Taiwan with bipolar II disorder comorbid and not comorbid with alcohol abuse/alcohol dependence disorder. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.78
International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord (2014) 4.10
A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg (2011) 3.30
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord (2012) 3.01
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry (2003) 2.69
Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania. Bipolar Disord (2003) 2.07
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord (2009) 1.91
The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC). Bipolar Disord (2010) 1.90
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry (2003) 1.84
Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.78
Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res (2011) 1.71
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication. J Affect Disord (2009) 1.64
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry (2005) 1.53
International Consensus Group on Bipolar I Depression Treatment Guidelines. J Clin Psychiatry (2004) 1.50
Oxcarbazepine in the treatment of bipolar disorder: a review. Can J Psychiatry (2006) 1.50
Functional neuroimaging of working memory in schizophrenia: task performance as a moderating variable. Neuropsychology (2006) 1.49
Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord (2008) 1.46
The impact of a history of psychotic symptoms on cognitive function in euthymic bipolar patients: a comparison with schizophrenic patients and healthy controls. Rev Bras Psiquiatr (2011) 1.46
Effect of electroconvulsive therapy on brain 5-HT(2) receptors in major depression. Br J Psychiatry (2010) 1.45
Clinical guidelines for depressive disorders. Summary of recommendations relevant to family physicians. Can Fam Physician (2003) 1.45
Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br J Psychiatry (2013) 1.43
Chronotherapeutics (light and wake therapy) in affective disorders. Psychol Med (2005) 1.42
Pharmacotherapy of bipolar II disorder: a critical review of current evidence. Bipolar Disord (2004) 1.41
Antidepressant effects of exercise: evidence for an adult-neurogenesis hypothesis? J Psychiatry Neurosci (2006) 1.41
Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry (2008) 1.40
Do the symptoms of bipolar disorder really show seasonal variation? Bipolar Disord (2013) 1.39
Recovery and recurrence following a first episode of mania: a systematic review and meta-analysis of prospectively characterized cohorts. J Clin Psychiatry (2015) 1.38
Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett (2006) 1.34
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. J Affect Disord (2009) 1.34
Does areca nut use lead to dependence? Drug Alcohol Depend (2008) 1.33
Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol (2008) 1.30
A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study [CME]. J Clin Psychiatry (2012) 1.30
Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis. J Psychiatry Neurosci (2006) 1.28
Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother (2009) 1.26
The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders. Ann Clin Psychiatry (2012) 1.18
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management. J Affect Disord (2009) 1.17
Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res (2006) 1.17
Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol Psychiatry (2006) 1.16
Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis. J Clin Psychiatry (2008) 1.14
Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial. Depress Anxiety (2010) 1.14
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments. J Affect Disord (2009) 1.14
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. J Affect Disord (2009) 1.12
Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry (2013) 1.12
Quality of life in bipolar disorder: a review of the literature. Health Qual Life Outcomes (2005) 1.11
[Performance of the Self-Reporting Questionnaire as a psychiatric screening questionnaire: a comparative study with Structured Clinical Interview for DSM-IV-TR]. Cad Saude Publica (2008) 1.09
Polytherapy in bipolar disorder. CNS Drugs (2006) 1.09
Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev Neurother (2008) 1.09
Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.08
Bipolar disorder and quality of life: a patient-centered perspective. Qual Life Res (2006) 1.08
Which antidepressants have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol (2007) 1.07
The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: an evolutionary perspective. Biol Psychiatry (2004) 1.07
Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients. Int Clin Psychopharmacol (2008) 1.07
The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response prediction. Curr Pharm Des (2012) 1.05
Perspectives for the development of animal models of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2004) 1.04
Mediators of allostasis and systemic toxicity in bipolar disorder. Physiol Behav (2011) 1.03
PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium. Am J Psychiatry (2002) 1.03
Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Rev Bras Psiquiatr (2011) 1.03
Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis. Bipolar Disord (2012) 1.02
A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. J Clin Psychiatry (2008) 1.02
Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathology. Bipolar Disord (2007) 1.01
Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord (2007) 1.01
A birth-season/DRD4 gene interaction predicts weight gain and obesity in women with seasonal affective disorder: A seasonal thrifty phenotype hypothesis. Neuropsychopharmacology (2006) 0.99
The association between attention-deficit/hyperactivity disorder and early-onset alcohol dependence: A retrospective study. Indian J Psychiatry (2008) 0.99
Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neurosci Lett (2007) 0.98
Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder. Biol Psychiatry (2010) 0.97
3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci (2009) 0.97
Effects of gabapentin on anxiety induced by simulated public speaking. J Psychopharmacol (2003) 0.96
DNA damage in bipolar disorder. Psychiatry Res (2007) 0.96
The interpersonal expression of perfection: perfectionistic self-presentation and psychological distress. J Pers Soc Psychol (2003) 0.96
Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode. J Clin Psychiatry (2010) 0.95
The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder. Ann Clin Psychiatry (2012) 0.95
The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord (2009) 0.95
Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res (2009) 0.94
Update on the biology of seasonal affective disorder. CNS Spectr (2005) 0.94